Merck Long-Term Investments 2010-2024 | MKKGY
Merck long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Merck long-term investments for the quarter ending June 30, 2024 were $1.147B, a 0.75% increase year-over-year.
- Merck long-term investments for 2023 were $1.065B, a 5.29% increase from 2022.
- Merck long-term investments for 2022 were $1.011B, a 6.46% decline from 2021.
- Merck long-term investments for 2021 were $1.081B, a 917.9% increase from 2020.
Merck Annual Long-Term Investments
(Millions of US $) |
| 2023 |
$1,065 |
| 2022 |
$1,011 |
| 2021 |
$1,081 |
| 2020 |
$106 |
| 2019 |
$827 |
| 2018 |
$720 |
| 2017 |
$502 |
| 2016 |
$241 |
| 2015 |
$146 |
| 2014 |
$125 |
| 2013 |
$103 |
| 2012 |
$125 |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Long-Term Investments
(Millions of US $) |
| 2024-06-30 |
$1,147 |
| 2024-03-31 |
$1,163 |
| 2023-12-31 |
$1,065 |
| 2023-09-30 |
$1,081 |
| 2023-06-30 |
$1,138 |
| 2023-03-31 |
$1,033 |
| 2022-12-31 |
$1,011 |
| 2022-09-30 |
$972 |
| 2022-06-30 |
$963 |
| 2022-03-31 |
$1,016 |
| 2021-12-31 |
$1,081 |
| 2021-09-30 |
$936 |
| 2021-06-30 |
$896 |
| 2021-03-31 |
$928 |
| 2020-12-31 |
$106 |
| 2020-09-30 |
$106 |
| 2020-06-30 |
$741 |
| 2020-03-31 |
$763 |
| 2019-12-31 |
$827 |
| 2019-09-30 |
$713 |
| 2019-06-30 |
$738 |
| 2019-03-31 |
$676 |
| 2018-12-31 |
$720 |
| 2018-09-30 |
$544 |
| 2018-06-30 |
$526 |
| 2018-03-31 |
$562 |
| 2017-12-31 |
$502 |
| 2017-09-30 |
$584 |
| 2017-06-30 |
$309 |
| 2017-03-31 |
$236 |
| 2016-12-31 |
$241 |
| 2016-09-30 |
$211 |
| 2016-06-30 |
$208 |
| 2016-03-31 |
$183 |
| 2015-12-31 |
$146 |
| 2015-09-30 |
$113 |
| 2015-06-30 |
$126 |
| 2015-03-31 |
$124 |
| 2014-12-31 |
$125 |
| 2014-09-30 |
$119 |
| 2014-06-30 |
$124 |
| 2014-03-31 |
$109 |
| 2013-12-31 |
$103 |
| 2013-09-30 |
$100 |
| 2013-06-30 |
$92 |
| 2013-03-31 |
$89 |
| 2012-12-31 |
$125 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
$5 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$6 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
